Wegovy is especially approved for weight loss, making it a highly effective obesity treatment, whereas Ozempic is generally used for type 2 diabetes
The KFF 2025 Employer Health Benefits Survey showed even faster acceleration: 43% of firms with 5,000+ workers now cover GLP-1s for weight loss (up from 28% in 2024), with 30% of firms with 1,0004,999 workers and 16% of firms with 200999 workers following suit ( [6] )
Direct answer: Recrea offers medical weight loss and hormone support resources that help maintain results
They named them glucagon-like peptide 1 and glucagon-like peptide 2, because scientists are very creative
Compounding is the process of combining, mixing, or altering ingredients to create a new type of medication
Right now, reliable long-term data do not exist